Personnel Information

写真a

KANNAGI Mari


Job title

Professor

Laboratory Address

Department of Immunotherapeutics, Tokyo Medical and Dental University Graduate School, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan

Laboratory Phone number

+81-3-5803-5798

Laboratory Fax number

+81-3-5803-0235

Graduating School 【 display / non-display

  • Kansai Medical University, Faculty of Medicine, 1979.03, Graduated

Graduate School 【 display / non-display

  • Kyoto University, Graduate School, Division of Medicine, Doctor's Course, Completed

Campus Career 【 display / non-display

  • 1995.04
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Bio-Environmental Response, Immunotherapeutics, Professor
  • 2018.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Bio-Environmental Response, Immunotherapeutics, Professor

External Career 【 display / non-display

  • 1979.06
    -
    1981.03
    , Trainee Resident
  • 1989.04
    -
    1991.05
    , Assistant Professor
  • 1991.06
    -
    1994.01
    , Junior Associate Professor
  • 1994.02
    -
    1995.03
    , Associate Professor

Research Areas 【 display / non-display

  • Immunology

  • Virology

  • Hematology

Qualification Acquired 【 display / non-display

  • Doctor

 

Published Papers & Misc 【 display / non-display

  • Mari Kannagi, Atsuhiko Hasegawa, Yoshiko Nagano, Tadafumi Iino, Jun Okamura, Youko Suehiro. Maintenance of long remission in adult T- cell leukemia by Tax- targeted vaccine: A hope for disease-preventive therapy Cancer Science. 2019.01; 110 849-857. ( DOI )

  • 末廣 陽子, 福田 哲也, 白土 基明, 飯野 忠史, 長谷川 温彦, 安永 純一朗, 平田 明恵, 宇都宮 勇人, 大野 博文, 石田 高司, 赤司 浩一, 松岡 雅雄, 神奈木 真理. ATLに対するTax標的樹状細胞ワクチン療法 第Ia/Ib相医師主導治験(Tax targeting dendritic cell vaccine for ATL: A phase Ia/Ib clinical study) 臨床血液. 2018.09; 59 (9): 1518. ( ichushi )

  • Leila Sawada, Yoshiko Nagano, Atsuhiko Hasegawa, Hikari Kanai, Kai Nogami, Sayaka Ito, Tomoo Sato, Yoshihisa Yamano, Yuetsu Tanaka, Takao Masuda, Mari Kannagi. IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways. PLoS Pathogens. 2017.09; 13 (9): e1006597.

  • Murakami, Y., A. Hasegawa, S. Ando, R. Tanaka, T. Masuda, Y. Tanaka, and M. Kannagi.. A novel mother-to-child HTLV-1 transmission model for investigating the role of maternal anti-HTLV-1 antibodies using orally infected mother rats. J Gen Virol . 2017.02; ( PubMed )

  • Ando S, Hasegawa A, Murakami Y, Zeng N, Takatsuka N, Maeda Y,T. Masuda, Y. Suehiro, and M. Kannagi.. HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax. J. Immunol. . 2017; 198 1210-1219.

display all >>

Conference Activities & Talks 【 display / non-display

  • Mari Kannagi . Host innate and acquired immune responses are the key factors for pathogenesis and therapy in HTLV-1 infection. The 30th International Workshop on Retroviral Pathogenesis Symposium 2018.10.11 Awaji

  • Kannagi M, Sawada L, Nagano Y, Kinpara S, Hasegawa A.. Involvement of antiviral innate responses in HTLV-1 leukemogenesis.. The 76th Annual Meeting of the Japanese Cancer Association 2017.10.25 Yokohama

  • Sawada L, Nagano Y, Hasegawa A, Ito S, Sato T, Yamano Y, Tanaka Y, Masuda T, ◯Kannagi M.. IL-10-mediated signals as a switch to proliferation in HTLV-1-infected T cells.. 18th International Conference on Human Retrovirology HTLV-1 and related viruses 2017.03.10 Tokyo

  • Mari Kannagi, Atsuhiko Hasegawa, Shuichi Kinpara, Youko Suehiro. The roles of acquired and innate immunity in HTLV1-infection: Implication for therapy and pathogenesis. . 2014.11.11

  • Kannagi M. Immune control of the retrovirus-induced adult T-cell leukemia: fighting with invisible enemy.. 2014.09.27

display all >>

Awards & Honors 【 display / non-display

  • Quality Award in Basic Science,18th International Conference on Human Retorovirology ,2017.03